1050 related articles for article (PubMed ID: 27989061)
21. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access.
Ussia GP; Cammalleri V; Marchetti AA; Sarkar K; De Vico P; Muscoli S; Sergi D; Marchei M; Ippoliti A; Romeo F
J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):271-8. PubMed ID: 25036268
[TBL] [Abstract][Full Text] [Related]
23. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
[TBL] [Abstract][Full Text] [Related]
24. Incidence, Predictors, and Mid-Term Outcomes of Percutaneous Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] Registry).
Nara Y; Watanabe Y; Kozuma K; Kataoka A; Nakashima M; Hioki H; Kawashima H; Nagura F; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Yamamoto M; Hayashida K
Am J Cardiol; 2017 Feb; 119(4):611-617. PubMed ID: 27939382
[TBL] [Abstract][Full Text] [Related]
25. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
26. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
Saleh N; De Palma R; Settergren M; Rück A
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
Androshchuk V; Chehab O; Prendergast B; Rajani R; Patterson T; Redwood S
Catheter Cardiovasc Interv; 2024 Jan; 103(1):169-185. PubMed ID: 37994240
[TBL] [Abstract][Full Text] [Related]
28. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
[TBL] [Abstract][Full Text] [Related]
29. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
[TBL] [Abstract][Full Text] [Related]
30. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
31. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
[TBL] [Abstract][Full Text] [Related]
32. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
[TBL] [Abstract][Full Text] [Related]
33. Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER).
Salizzoni S; D'Onofrio A; Agrifoglio M; Colombo A; Chieffo A; Cioni M; Besola L; Regesta T; Rapetto F; Tarantini G; Napodano M; Gabbieri D; Saia F; Tamburino C; Ribichini F; Cugola D; Aiello M; Sanna F; Iadanza A; Pompei E; Stefàno P; Cappai A; Minati A; Cassese M; Martinelli GL; Agostinelli A; Fiorilli R; Casilli F; Reale M; Bedogni F; Petronio AS; Mozzillo RA; Bonmassari R; Briguori C; Liso A; Sardella G; Bruschi G; Fiorina C; Filippini C; Moretti C; D'Amico M; La Torre M; Conrotto F; Di Bartolomeo R; Gerosa G; Rinaldi M;
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1139-1148. PubMed ID: 27406375
[TBL] [Abstract][Full Text] [Related]
34. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
[TBL] [Abstract][Full Text] [Related]
36. Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves.
Fischer Q; Urena M; Bouleti C; Abtan J; Brochet E; Carrasco JL; Iung B; Vahanian A; Himbert D
Arch Cardiovasc Dis; 2019; 112(8-9):512-522. PubMed ID: 31474571
[TBL] [Abstract][Full Text] [Related]
37. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
[TBL] [Abstract][Full Text] [Related]
38. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation.
Van Mieghem NM; Tchetche D; Chieffo A; Dumonteil N; Messika-Zeitoun D; van der Boon RM; Vahdat O; Buchanan GL; Marcheix B; Himbert D; Serruys PW; Fajadet J; Colombo A; Carrié D; Vahanian A; de Jaegere PP
Am J Cardiol; 2012 Nov; 110(9):1361-7. PubMed ID: 22819428
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
[TBL] [Abstract][Full Text] [Related]
40. Suprasternal Transcatheter Aortic Valve Replacement in Patients With Marginal Femoral Access.
Kiser AC; Caranasos TG; Peterson MD; Holzhey DM; Kiefer P; Nifong LW; Borger MA
Innovations (Phila); 2018; 13(1):1-4. PubMed ID: 29462049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
